Aier Eye Hospital Group Co Ltd banner
A

Aier Eye Hospital Group Co Ltd
SZSE:300015

Watchlist Manager
Aier Eye Hospital Group Co Ltd
SZSE:300015
Watchlist
Price: 10.41 CNY 5.58% Market Closed
Market Cap: ¥97.1B

EV/EBIT

21.4
Current
17%
Cheaper
vs 3-y average of 25.7

Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.

EV/EBIT
21.4
=
Enterprise Value
¥89.8B
/
EBIT
¥4.5B

Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.

EV/EBIT
21.4
=
Enterprise Value
¥89.8B
/
EBIT
¥4.5B

Valuation Scenarios

Aier Eye Hospital Group Co Ltd is trading below its 3-year average

If EV/EBIT returns to its 3-Year Average (25.7), the stock would be worth ¥12.48 (20% upside from current price).

Statistics
Positive Scenarios
4/4
Maximum Downside
No Downside Scenarios
Maximum Upside
+59%
Average Upside
38%
Scenario EV/EBIT Value Implied Price Upside/Downside
Current Multiple 21.4 ¥10.41
0%
3-Year Average 25.7 ¥12.48
+20%
5-Year Average 34 ¥16.5
+59%
Industry Average 29.4 ¥14.28
+37%
Country Average 28.9 ¥14.03
+35%

Forward EV/EBIT
Today’s price vs future ebit

Today's Enterprise Value EBIT Forward EV/EBIT
¥89.8B
/
Oct 2025
¥4.5B
=
21.4
Current
¥89.8B
/
Dec 2025
¥5.1B
=
17.6
Forward
¥89.8B
/
Dec 2026
¥5.9B
=
15.3
Forward
¥89.8B
/
Dec 2027
¥6.7B
=
13.5
Forward

Forward EV/EBIT shows whether today’s EV/EBIT still looks high or low once future ebit are taken into account.

Peer Comparison

All Multiples
EV/EBIT
P/E
All Countries
Close

Market Distribution

In line with most companies in China
Percentile
39th
Based on 5 337 companies
39th percentile
21.4
Low
0 — 16.6
Typical Range
16.6 — 52.9
High
52.9 —
Distribution Statistics
China
Min 0
30th Percentile 16.6
Median 28.9
70th Percentile 52.9
Max 49 021

Aier Eye Hospital Group Co Ltd
Glance View

Market Cap
97.1B CNY
Industry
Health Care

Aier Eye Hospital Group Co., Ltd., having risen prominently in the medical services sector, narrates a compelling story of growth and innovation. Founded in 2003 and headquartered in Changsha, China, Aier Eye Hospital embodies the vision of providing comprehensive eye care services across the nation and beyond. Its journey began with a singular focus on ophthalmology, and over the years, it meticulously expanded its network, now operating hundreds of specialized eye clinics and hospitals domestically and internationally. This network offers services ranging from basic eye examinations to complex surgeries, such as cataract removal and refractive surgery. The company reached a notable milestone by successfully integrating modern medical technology with a patient-centric service model, ensuring that its facilities are equipped with state-of-the-art technology to deliver high-quality ophthalmic care. Aier Eye Hospital derives its revenue primarily from providing these medical services, supported by strategic acquisitions and partnerships that enhance its spectrum of offerings and geographic footprint. Its business model deftly combines volume-driven profitability with high-quality care, allowing it to maintain a leadership position in the industry. Education and research form additional pillars of its operational strategy; Aier emphasizes the continuous training of its medical staff and engages in research initiatives, thus fostering an environment of innovation that further solidifies its competitive edge. This blend of strategic growth, patient-focused service, and technological advancement enables Aier Eye Hospital Group to not only cater to a growing demand for eye care services but also chart a course of sustained financial health and expansion.

Intrinsic Value
12.47 CNY
Undervaluation 16%
Intrinsic Value
Price ¥10.41
A
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett